These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2261791)

  • 21. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psoriatic arthritis: a diagnostic challenge?
    Buder K; Wozel G
    G Ital Dermatol Venereol; 2010 Jun; 145(3):407-14. PubMed ID: 20461048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Juvenile psoriatic arthritis].
    Lu S; Zhou W; Zhang Q; Yu XY; Liu DM; Liu XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):339-42. PubMed ID: 17706035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of psoriatic arthritis in a population of patients with psoriasis].
    Jajić Z; el Assadi G
    Acta Med Croatica; 2003; 57(4):323-6. PubMed ID: 14639870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarkers for comorbidities in psoriasis: a report from the GRAPPA 2011 annual meeting.
    Gladman DD
    J Rheumatol; 2012 Nov; 39(11):2193-5. PubMed ID: 23118285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subpopulations within juvenile psoriatic arthritis: a review of the literature.
    Stoll ML; Nigrovic PA
    Clin Dev Immunol; 2006; 13(2-4):377-80. PubMed ID: 17162381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leflunomide in psoriatic arthritis.
    Kaltwasser JP
    Autoimmun Rev; 2007 Sep; 6(8):511-4. PubMed ID: 17854740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI).
    Mease PJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S64-85. PubMed ID: 22588772
    [No Abstract]   [Full Text] [Related]  

  • 31. Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report.
    Biondi Oriente C; Scarpa R; Pucino A; Oriente P
    Acta Derm Venereol Suppl (Stockh); 1989; 146():69-71. PubMed ID: 2609889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
    Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
    BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different aspects of psoriasis: analysis of 150 Iranian patients.
    Moghaddassi M; Shahram F; Chams-Davatchi C; Najafizadeh SR; Davatchi F
    Arch Iran Med; 2009 May; 12(3):279-83. PubMed ID: 19400606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psoriatic arthritis. Diverse and sometimes highly destructive.
    Bulbul R; Williams WV; Schumacher HR
    Postgrad Med; 1995 Apr; 97(4):97-9, 103-6, 108. PubMed ID: 7716095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
    Makredes M; Robinson D; Bala M; Kimball AB
    J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psoriatic arthritis. New types, new treatments.
    Ruzicka T
    Arch Dermatol; 1996 Feb; 132(2):215-9. PubMed ID: 8629831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a preliminary composite disease activity index in psoriatic arthritis.
    Mumtaz A; Gallagher P; Kirby B; Waxman R; Coates LC; Veale J D; Helliwell P; FitzGerald O
    Ann Rheum Dis; 2011 Feb; 70(2):272-7. PubMed ID: 21115550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psoriatic arthritis: from a dermatological perspective.
    Yamamoto T
    Eur J Dermatol; 2011; 21(5):660-6. PubMed ID: 21715249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Five-year outcome of a primary-care-based inception cohort of patients with inflammatory polyarthritis plus psoriasis.
    Morgan C; Lunt M; Bunn D; Scott DG; Symmons DP
    Rheumatology (Oxford); 2007 Dec; 46(12):1819-23. PubMed ID: 18032539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ustekinumab for psoriasis and psoriatic arthritis.
    Goldminz AM; Gottlieb AB
    J Rheumatol Suppl; 2012 Jul; 89():86-9. PubMed ID: 22751602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.